School of Medicine


Showing 1-10 of 35 Results

  • Saurabh Dahiya, MD, FACP

    Saurabh Dahiya, MD, FACP

    Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

    BioDr. Dahiya is a cancer specialist with board certification in internal medicine, hematology, and medical oncology. He is an Associate Professor at Stanford University School of Medicine and Clinical Director of Cancer Cell Therapy in the Stanford BMT and Cell Therapy division.

    Dr. Dahiya strives to support each patient with a personalized and compassionate care plan that optimizes healing and quality of life.

    Prior to joining Stanford, Dr. Dahiya was an associate professor of medicine at the Greenebaum Comprehensive Cancer Center at the University of Maryland School of Medicine, where he developed the Cellular Immunotherapy Program and served as the Director of Cellular Immunotherapy in leukemia and lymphoma.

    Dr. Dahiya’s research focuses on cellular immunotherapy for hematologic malignancies. He has led and participated in several investigator-initiated studies and sponsored clinical trials with cell therapies (CAR-T, CAR-NK, TCR-T) for hematologic malignancies. His research group is also involved in various translational research activities for the standard of care and research CAR-T therapy. Dr. Dahiya’s group was the first group to show the role of fibrinogen in Neurotoxicity associated with CAR-T therapy. They showed vascular injury as manifested by high fibrinogen levels is associated with higher Neurotoxicity in patients who receive CAR-T therapy. More recently his group led a novel study of assessing the immune response to COVID-19 disease. They evaluated the immune response in critically ill and non-critically ill patients hospitalized with COVID-19 disease and showed a differential immune response between the groups. Dr. Dahiya’s group also showed and established poor immunogenicity of COVID-19 vaccines in CART recipients. As such, passive immunity and other strategies to address the issues of immunogenicity are being explored.

    He has published more than 50 articles in peer-reviewed journals including the New England Journal of Medicine, Journal of Clinical Oncology, Blood, Blood Advances, Lancet, Leukemia Research, Neuro-Oncology, and many more. He reviews article submissions for the journals Critical Reviews in Oncology and Hematology, Thoracic Cancer, and Blood. He serves as the hematology lead editor for the journal Critical Reviews in Oncology and Hematology.

    He has presented his research findings at conferences such as the annual meetings of the American Society of Hematology, American Society of Clinical Oncology, and American Society for Transplantation and Cell Therapy.

    Dr. Dahiya is a member of the American Society of Hematology and the American Society of Transplantation and Cell Therapy.

  • Sudeb C. Dalai

    Sudeb C. Dalai

    Adjunct Clinical Assistant Professor, Medicine - Infectious Diseases

    BioDr. Sudeb Dalai, MD PhD is an Infectious Disease Physician at Stanford University School of Medicine and the Palo Alto Medical Foundation. Currently a Clinical Assistant Professor (Teaching) at Stanford, he has taught courses and conducted research in academia/industry for over 18 years.

    Dr. Dalai completed his undergraduate degree at MIT, MD and MS at Stanford, PhD in Epidemiology at UC Berkeley School of Public Health, Internal Medicine Residency at UCSD, and Fellowship in Infectious Diseases at Stanford. He has received numerous teaching and leadership awards and research grants and has co-authored multiple peer-reviewed publications. His work has been supported by the Infectious Diseases Society of America, the Howard Hughes Medical Institute, the Paul and Daisy Soros Foundation, and the National Institutes of Health. Dr. Dalai is an internationally-invited speaker and has been featured in multiple media outlets including ABC, NBC, Good Morning America, US News & World Report, Buzzfeed, and The Huffington Post. In 2003 he was elected to the MIT Board of Trustees and in 2020 he was voted as a Board Member of the MIT Club of Northern California.

  • Millie Das

    Millie Das

    Clinical Associate Professor, Medicine - Oncology

    BioDr. Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis. She has a strong interest in clinical research, serving as a principal investigator for multiple clinical and translational studies at the Palo Alto VA, and also as a co-investigator on all of the lung cancer trials at Stanford. In her free time, she enjoys spending time with her family, traveling, and running.

  • Rajesh Dash, MD PhD;      Director of SSATHI & CardioClick

    Rajesh Dash, MD PhD; Director of SSATHI & CardioClick

    Associate Professor of Medicine (Cardiovascular Medicine)

    Current Research and Scholarly InterestsI have two research areas:
    1) Heart disease in South Asians - genetic, metabolic, & behavioral underpinnings of an aggressive phenotype.

    2) Imaging cell injury & recovery in the heart. Using Cardiac MRI to visualize signals of early injury and facilitating preventive medical therapy. Optimizing new imaging methods for viable cells to delineate live heart cells or transplanted stem cells.

  • Tami Daugherty

    Tami Daugherty

    Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

    Current Research and Scholarly InterestsDr. Daugherty is a transplant Hepatologist with full-time clinical responsibilities. She is particularly interested in the natural course and management of recurrent Hepatitis C after liver transplant, and the effect of immunosuppression on HCV recurrence.

  • Aglaia Kaissa de Boer

    Aglaia Kaissa de Boer

    Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    BioKaïssa de Boer, MD is a board certified pulmonologist who specializes in the care of patients with interstitial lung disease. She completed her Internal Medicine and Pulmonary training at the University of Ottawa, Ottawa, Canada where her initial interest in caring for patients with fibrotic lung disease first developed. Subsequently she completed a fellowship in Interstitial Lung Disease at the University of California, San Francisco under the direction of Dr. Harold Collard. Dr. de Boer has a special interest in patients with connective tissue disease associated lung disease and those with drug induced pneumonitis. In addition she is actively involved in the ILD training and program development of Stanford's Pulmonary Allergy and Critical Care Fellows.

  • Korina De Bruyne

    Korina De Bruyne

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    Current Research and Scholarly InterestsThe EMPOWER study (PI: Dr Beth Darnall) is looking at how to best support patients with chronic pain on long-term opioid therapy through a slow taper (maximal duration of 1 year). Patients are randomized to taper only versus taper plus community-based pain self-management group sessions versus taper plus psychologist-led cognitive behavioral therapy for pain group sessions. Along the way alternative measures to control pain are also explored. Enrollment is open until 10/2021.

  • Vinicio de Jesus Perez MD

    Vinicio de Jesus Perez MD

    Associate Professor of Medicine (Pulmonary and Critical Care Medicine)

    Current Research and Scholarly InterestsMy work is aimed at understanding the molecular mechanisms involved in the development and progression of pulmonary arterial hypertension (PAH). I am interested in understanding the role that the BMP and Wnt pathways play in regulating functions of pulmonary endothelial and smooth muscle cells both in health and disease.